Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Xiu‑Tao Fu"'
Autor:
Pei-Yun Zhou, Cheng Zhou, Wei Gan, Zheng Tang, Bao-Ye Sun, Jin-Long Huang, Gao Liu, Wei-Ren Liu, Meng-Xin Tian, Xi-Fei Jiang, Han Wang, Chen-Yang Tao, Yuan Fang, Wei-Feng Qu, Run Huang, Gui-Qi Zhu, Cheng Huang, Xiu-Tao Fu, Zhen-Bin Ding, Qiang Gao, Jian Zhou, Ying-Hong Shi, Yong Yi, Jia Fan, Shuang-Jian Qiu
Publikováno v:
Communications Biology, Vol 6, Iss 1, Pp 1-17 (2023)
Abstract Primary liver cancer (PLC) poses a leading threat to human health, and its treatment options are limited. Meanwhile, the investigation of homogeneity and heterogeneity among PLCs remains challenging. Here, using single-cell RNA sequencing, s
Externí odkaz:
https://doaj.org/article/7116ab23faf54dce9c04956d710085f8
Autor:
Zheng Gao, Shan-Ru Feng, Jia‑Feng Chen, Xiao‑Gang Li, Ying‑Hong Shi, Zheng Tang, Wei‑Ren Liu, Xin Zhang, Ao Huang, Xuan‑Ming Luo, Hai-Ying Zeng, Qiang Gao, Guo‑Ming Shi, Ai‑Wu Ke, Jian Zhou, Jia Fan, Xiu‑Tao Fu, Zhen‑Bin Ding
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 161, Iss , Pp 114560- (2023)
Hepatocellular carcinoma (HCC) has a complex and changeable tumor microenvironment. Despite emerging evidence focusing on autophagy process within immune cells, the function and regulatory mechanism of macrophage autophagy in tumor progression remain
Externí odkaz:
https://doaj.org/article/24682435c4214c099f1a7c596e7ff5a5
Autor:
Zheng Gao, Jia-Feng Chen, Xiao-Gang Li, Ying-Hong Shi, Zheng Tang, Wei-Ren Liu, Xin Zhang, Ao Huang, Xuan-Ming Luo, Qiang Gao, Guo-Ming Shi, Ai-Wu Ke, Jian Zhou, Jia Fan, Xiu-Tao Fu, Zhen-Bin Ding
Publikováno v:
Cancer Cell International, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background While the correlation between PD-L1 expression and KRAS mutation has been previously reported in other solid tumors such as non-small cell lung cancer (NSCLC), whether PD-L1 can be modulated by ERK signaling downstream of KRAS in
Externí odkaz:
https://doaj.org/article/333fa9d23fd04e279c13aed5e784ca44
Autor:
Xin Xu, Ao Huang, De-Zhen Guo, Yu-Peng Wang, Shi-Yu Zhang, Jia-Yan Yan, Xin-Yu Wang, Ya Cao, Jia Fan, Jian Zhou, Xiu-Tao Fu, Ying-Hong Shi
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundTumor recurrence after hepatectomy is high for hepatocellular carcinoma (HCC), and minimal residual disease (MRD) could be the underlying mechanism. A predictive model for recurrence and presence of MRD is needed.MethodsCommon inflammation-
Externí odkaz:
https://doaj.org/article/2c3267de46674958a686769bfd135065
Autor:
Xiu-Tao Fu, Kang Song, Jian Zhou, Ying-Hong Shi, Wei-Ren Liu, Guo-Ming Shi, Qiang Gao, Xiao-Ying Wang, Zhen-Bin Ding, Jia Fan
Publikováno v:
Cancer Cell International, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Oxaliplatin-based chemotherapy is widely used to treat hepatocellular carcinoma (HCC). Recent studies suggested that therapeutic resistance of tumors was affected by tumor microenvironment (TME). As a major component of TME, the r
Externí odkaz:
https://doaj.org/article/adccfa4f200c4306ab6b28a211114581
Autor:
Jia-Feng Chen, Xiu-Tao Fu, Zheng Gao, Ying-Hong Shi, Zheng Tang, Wei-Ren Liu, Xin Zhang, Qiang Gao, Guang-Yu Ding, Kang Song, Xiao-Ying Wang, Jian Zhou, Jia Fan, Zhen-Bin Ding
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Background: It remains unclear whether the short-term benefits of laparoscopic repeat hepatectomy (LRH) accrue to patients with recurrent liver tumors. The present study aimed to report our own center's experience and perform a meta-analysis to evalu
Externí odkaz:
https://doaj.org/article/7c98bfbe3856456d96d11eea0907ea49
Autor:
Xiu-Tao Fu, Ying-Hong Shi, Jian Zhou, Yuan-Fei Peng, Wei-Ren Liu, Guo-Ming Shi, Qiang Gao, Xiao-Ying Wang, Kang Song, Jia Fan, Zhen-Bin Ding
Publikováno v:
Infectious Agents and Cancer, Vol 12, Iss 1, Pp 1-8 (2017)
Abstract Background The conception that serological hepatitis markers determined surgical prognosis of hepatocellular carcinoma (HCC) associated with hepatitis B (HBV) or hepatitis C (HCV) has been well defined. However, little is known about the rel
Externí odkaz:
https://doaj.org/article/d8efaf601ac74b3f859591386d8ba881
Autor:
Wei-Feng Qu, Zhen-Bin Ding, Xu-Dong Qu, Zheng Tang, Gui-Qi Zhu, Xiu-Tao Fu, Zi-Han Zhang, Xin Zhang, Ao Huang, Min Tang, Meng-Xin Tian, Xi-Fei Jiang, Run Huang, Chen-Yang Tao, Yuan Fang, Jun Gao, Xiao-Ling Wu, Jian Zhou, Jia Fan, Wei-Ren Liu, Ying-Hong Shi
Publikováno v:
BJS Open. 6
Background Combination conversion therapies afforded curative surgery chance for initially unresectable hepatocellular carcinoma (uHCC). This study aimed to evaluate the conversion rate and clinical outcomes of a first-line conversion regimen of lenv
Autor:
Ao Huang, Jia-Feng Chen, Jian-Zhang Wu, Zheng Gao, Ying-Hong Shi, Xiu-Tao Fu, Xin Zhang, Wei-Ren Liu, Qiang Gao, Hui-Chuan Sun, Guo-Ming Shi, Jia Fan, Zhen-Bin Ding, Jian Zhou
Publikováno v:
Journal of Oncology.
Background. Avatrombopag has been approved in patients who have severe thrombocytopenia ( P = 0.594 ), while patients without CLD had higher peak platelet (median, 134.0 × 109/L vs. 74.0 × 109/L; P = 0.015 ) and absolute increase (median, 101.0 ×
Autor:
Zheng Gao, Jia-Feng Chen, Xiao-Gang Li, Ying-Hong Shi, Zheng Tang, Wei-Ren Liu, Xin Zhang, Ao Huang, Xuan-Ming Luo, Qiang Gao, Guo-Ming Shi, Ai-Wu Ke, Jian Zhou, Jia Fan, Xiu-Tao Fu, Zhen-Bin Ding
Publikováno v:
Cancer cell international. 22(1)
Background While the correlation between PD-L1 expression and KRAS mutation has been previously reported in other solid tumors such as non-small cell lung cancer (NSCLC), whether PD-L1 can be modulated by ERK signaling downstream of KRAS in intrahepa